Article Text

PDF
Systematic review
Lung cancer screening with low-dose CT (LDCT) is ready for prime time in the USA
  1. David O Wilson
  1. Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
  1. Correspondence to: Dr David O Wilson, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, 580 S. Aiken Avenue, #400, Pittsburgh, PA 15217, USA; wilsondo{at}upmc.edu

Statistics from Altmetric.com

Commentary on: OpenUrlCrossRefPubMedWeb of Science

Context

The US Preventative Services Task Force (USPSTF) has published their long-awaited, updated systematic review of low-dose CT (LDCT) screening for lung cancer. Last reviewed in 2004, lung cancer screening has been under intense study worldwide for the past decade. The issue of lung cancer screening is important because lung cancer is the leading cause of cancer mortality in the USA and any method that improves lung cancer early detection and diagnosis has the potential to significantly impact …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.